ethinyl estradiol has been researched along with Insulin Sensitivity in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (5.71) | 18.7374 |
1990's | 7 (10.00) | 18.2507 |
2000's | 18 (25.71) | 29.6817 |
2010's | 37 (52.86) | 24.3611 |
2020's | 4 (5.71) | 2.80 |
Authors | Studies |
---|---|
Cereijo, R; de Zegher, F; García-Beltran, C; Ibáñez, L; López-Bermejo, A; Malpique, R; Quesada-López, T; Villarroya, F | 1 |
Anoka, NA; Lawrence, OA; Olufunmilayo, OM; Olufunto, BO | 1 |
Huo, P; Jiang, Z; Le, J; Lei, X; Tang, Q; Tu, H; Yao, J; Zhang, R; Zhang, S | 1 |
Artini, PG; Battaglia, B; Battaglia, C; Casadio, P; Rizzo, R | 1 |
Adeyanju, OA; Areola, ED; Michael, OS; Olatunji, LA; Soladoye, AO | 1 |
Abolarinwa, BA; Achile, CJ; Kim, IK; Olaniyi, KS; Olatunji, LA; Usman, TO | 1 |
Andersen, M; Christensen, MMH; Glintborg, D; Pedersen, AJT; Stage, TB | 1 |
Michael, OS; Olatunji, LA | 1 |
Gu, M; Mueck, AO; Ruan, X; Song, J; Wang, H; Wang, L | 2 |
Adeyanju, OA; Olatunji, LA; Soetan, OA; Soladoye, AO | 1 |
Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L | 1 |
Michael, OS; Olatunji, LA; Omolekulo, TE | 1 |
Mohanty, J; Nagy, A; Sahu, A; Tripathy, P | 1 |
Shi, Y; Tang, L; Ye, J; Zhu, X | 1 |
Aguiar, GS; Bonfleur, ML; Boschero, AC; Clarke, JR; da Silva Junior, JA; Dos Reis Araujo, T; Freitas, IN; Henriques, HN; Oliveira, CAR; Oliveira, KM; Ribeiro, RA; Vettorazzi, JF | 1 |
Amin, S; Bhat, IA; Fatima, Q; Ganie, MA; Jeelani, H; Kawa, IA; Manzoor, S; Rashid, F; Shah, ZA; Yousuf, SD | 1 |
Olaniyi, KS; Olatunji, LA | 1 |
Jelenik, T; Roden, M | 1 |
de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Marcos, MV; Sebastiani, G | 1 |
Akdeniz, D; Carlioglu, A; Gumus, II; Karakurt, F; Kaygusuz, I; Uz, B | 1 |
Cagnacci, A; Piacenti, I; Tirelli, A; Xholli, A; Zanin, R | 1 |
Aksoy, A; Carlioglu, A; Gozukara, I; Kabil Kucur, S; Kamalak, Z; Keskin, H; Uludag, EU | 1 |
Cim, N; Gokce, AI; Yildizhan, B; Yildizhan, R | 1 |
Chen, A; Du, J; Du, Y; Liao, YC; Lin, XF; Wang, Y; Wu, C; Wu, RR; Ye, Y; Zhang, XB | 1 |
Baracat, EC; Consolim-Colombo, FM; Giribela, AH; Giribela, CR; Melo, NR; Moraes, TL; Nisenbaum, MG | 1 |
Sun, X; Wu, X; Yu, X; Zhang, W; Zhou, Y | 1 |
Jiang, M; Ma, F; Qi, J; Qiao, L; Wang, L; Xie, S; Xu, K; Yue, H; Zhang, W; Zhou, X | 1 |
Hutchison, SK; McGrath, BP; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S | 1 |
Cagnacci, A; Ferrari, S; Tirelli, A; Volpe, A; Zanin, R | 1 |
Alacacioglu, A; Kebapcilar, AG; Kebapcilar, L; Sari, I; Taner, CE | 1 |
Kuhl, H; Lange, E; Manthey, T; Mellinger, U; Mittmann, K; Palombo-Kinne, E; Sänger, N; Stahlberg, S; Wiegratz, I | 1 |
Bilgir, O; Bozkaya, G; Kebapcilar, AG; Kebapcilar, L; Sari, I; Taner, CE; Yildiz, Y | 1 |
Decavalas, G; Diamanti-Kandarakis, E; Georgopoulos, NA; Katsikis, I; Panidis, D; Piouka, A; Saltamavros, AD | 1 |
Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW | 1 |
Cheang, KI; Essah, PA; Nestler, JE; Sharma, S; Wickham, EP | 1 |
Adawadkar, SS; Arrowood, JA; Cheang, KI; Essah, PA; Nestler, JE; Stovall, DW | 1 |
Diedrich, K; Friedrich, A; Jauch-Chara, K; Loebig, M; Ludwig, AK; Oltmanns, KM; Rudolf, S; Schweiger, U; Tauchert, S | 1 |
Demirlenk, S; Karabulut, A; Sevket, O | 1 |
Basu, R; Bhattacharya, SM; Ghosh, M | 1 |
Beasley, A; Estes, C; Guerrero, J; Westhoff, C | 1 |
DiVasta, AD; Veilleux-Lemieux, M | 1 |
Birla, S; Jain, R; Jain, V; Sharma, A; Verma, N | 1 |
Dahlgren, E; Holm, G; Janson, PO; Krotkiewski, M; Landin, K | 2 |
Cagnacci, A; Melis, GB; Orrù, M; Paoletti, AM; Pilloni, M; Renzi, A; Volpe, A | 1 |
Fleming, R; Harborne, L; Lyall, H; Norman, J; Sattar, N | 1 |
Mitkov, M; Pehlivanov, B; Terzieva, D | 1 |
Déchêne, F; Dodin, S; Forest, JC; Lemay, A; Turcot, L | 1 |
Cagnacci, A; Paoletti, AM; Renzi, A; Tirelli, A; Volpe, A | 1 |
Charitidou, C; Farmakiotis, D; Hatzistilianou, M; Karamanis, N; Katsikis, I; Panidis, D; Pegiou, T; Pidonia, I; Zournatzi, V | 1 |
Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Lasunción, MA; Luque-Ramírez, M; Martínez-Bermejo, E | 1 |
Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Luque-Ramírez, M; San Millán, JL; Sanchón, R | 1 |
Barbonetti, A; Colangeli, MS; D'Angeli, A; Francavilla, F; Francavilla, S; Necozione, S; Pandolfi, C; Vassallo, MR; Zugaro, A | 1 |
Baser, I; Dede, M; Erbil, MK; Kenar, L; Oktenli, C; Ozgurtas, T; Sanisoglu, SY; Tapan, S; Yenen, MC; Yesilova, Z | 1 |
Harrison, C; Hutchison, SK; Meyer, C; Stepto, N; Teede, HJ | 1 |
Godsland, IF; Jacobs, HS; Seed, M; Wynn, V | 1 |
Azen, CG; Bergman, RN; Perlman, JA; Roy, S; Watanabe, RM | 1 |
Asscheman, H; Bakker, A; Gooren, LJ; Heine, RJ; Polderman, KH | 1 |
Wilson, L; Zemtsov, A | 1 |
Bi, Y; Wang, H; Wu, J | 1 |
Andersen, LF; Christiansen, E; Jespersen, J; Madsbad, S; Petersen, KR; Skouby, SO | 1 |
Koivunen, RM; Martikainen, HK; Morin-Papunen, LC; Ruokonen, A; Tapanainen, JS; Vauhkonen, I | 1 |
Escobar-Morreale, HF; Lasunción, MA; Sancho, J | 1 |
Dolphin, PJ; Dubé, PJ; McKendrick, JD; Radomski, MW; Russell, JC | 1 |
Gogate, JG; Shringi, MS; Vaidya, AB; Vaidya, RA | 1 |
Durmusoglu, F; Elter, K; Imir, G | 1 |
Andersen, O; Kühl, C; Saurbrey, N; Skouby, SO | 1 |
Moore, DC | 1 |
Gossain, VV; Michelakis, AM; Rovner, DR; Sherma, NK | 1 |
34 trial(s) available for ethinyl estradiol and Insulin Sensitivity
Article | Year |
---|---|
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemokines, CXC; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gene Expression; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Hypoglycemic Agents; Insulin Resistance; Intellectual Disability; Levonorgestrel; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome | 2020 |
The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial.
Topics: Adult; Ataxia Telangiectasia Mutated Proteins; Biomarkers; Blood Glucose; Contraceptives, Oral, Hormonal; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Organic Anion Transport Protein 1; Organic Cation Transport Proteins; Pharmacogenetics; Pharmacogenomic Variants; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Triglycerides; Weight Loss; Young Adult | 2018 |
Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Treatment Outcome | 2018 |
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.
Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult | 2018 |
Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
Topics: Adult; Androgen Antagonists; Androgens; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Metformin; Ovary; Polycystic Ovary Syndrome; Prospective Studies; Regional Blood Flow; Testosterone; Ultrasonography, Doppler, Color; Waist Circumference | 2019 |
Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.
Topics: Adiposity; Adolescent; Adolescent Development; Androgen Antagonists; Body Mass Index; C-Reactive Protein; Carotid Intima-Media Thickness; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Menstruation Disturbances; Overweight; Tunica Intima; Vascular Diseases | 2013 |
Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up.
Topics: Adult; Androstenes; Blood Glucose; Blood Pressure; C-Reactive Protein; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Insulin Resistance; Longitudinal Studies; Luteinizing Hormone; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides; Waist-Hip Ratio; Young Adult | 2015 |
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Vasodilation; von Willebrand Factor | 2010 |
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Chlormadinone Acetate; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Liver Function Tests; Luteinizing Hormone; Young Adult | 2009 |
Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
Topics: Adult; Blood Coagulation; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Weight Loss; Young Adult | 2010 |
Effects of combined oral contraceptive ethinylestradiol (30 microg) and dienogest (2 mg) on carbohydrate metabolism during 1 year of conventional or extended-cycle use.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Menstruation; Nandrolone; Prospective Studies; Young Adult | 2010 |
Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients.
Topics: Adult; Androgen Antagonists; Body Mass Index; CD40 Antigens; Contraceptives, Oral; Cyproterone Acetate; Dose-Response Relationship, Drug; Down-Regulation; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Young Adult | 2011 |
The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Anti-Mullerian Hormone; Blood Glucose; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Young Adult | 2011 |
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones | 2011 |
Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women.
Topics: Academic Medical Centers; Adult; Analysis of Variance; Blood Glucose; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Lipoproteins, LDL; Norgestrel; Obesity; Prospective Studies; Thinness; Time Factors; Virginia; Young Adult | 2011 |
Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Norgestrel; Obesity; Overweight; Placebo Effect; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Vasodilation; Virginia | 2011 |
Effects of ethinyl estradiol and desogestrel on clinical and metabolic parameters in Indian patients with polycystic ovary syndrome.
Topics: Acne Vulgaris; Adolescent; Adult; Blood Glucose; Body Composition; Body Mass Index; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; India; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Progestins; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2012 |
The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Medication Adherence; Obesity; Patient Dropouts; Triglycerides; Young Adult | 2012 |
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.
Topics: Adult; Anthropometry; Blood Glucose; Body Weight; C-Peptide; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Hormones; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome | 2003 |
Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Anthropometry; Blood Glucose; Blood Pressure; Body Mass Index; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Polycystic Ovary Syndrome; Sebum | 2003 |
Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Waist-Hip Ratio | 2005 |
Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
Topics: Adolescent; Adult; Androgens; Blood Glucose; Cholesterol, HDL; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Middle Aged; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones | 2006 |
Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Contraceptives, Oral; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Folic Acid; Homocysteine; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Vitamin B 12 | 2006 |
The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome | 2008 |
Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Androgen Antagonists; Androgens; Blood Glucose; Cardiovascular Diseases; Cyproterone Acetate; Drug Combinations; Dyslipidemias; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Polycystic Ovary Syndrome; Risk Factors | 2007 |
Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Ferritins; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iron; Metformin; Obesity; Oligomenorrhea; Polycystic Ovary Syndrome | 2007 |
Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome.
Topics: Adult; Body Mass Index; Contraceptives, Oral; Cyproterone; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Overweight; Polycystic Ovary Syndrome; Retinol-Binding Proteins, Plasma; Waist-Hip Ratio | 2008 |
Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors.
Topics: Adolescent; Adult; B-Lymphocytes; Carbohydrate Metabolism; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin Resistance; Metabolic Diseases; Norgestrel; Risk Factors | 1994 |
[The effects of ethinyl estradiol on glucose metabolism in postmenopausal women].
Topics: Blood Glucose; Estradiol Congeners; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Middle Aged; Postmenopause | 1997 |
Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Goserelin; Hirsutism; Humans; Insulin Resistance; Lipids; Polycystic Ovary Syndrome | 1998 |
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.
Topics: Adult; Antibodies, Monoclonal; Blood Glucose; C-Peptide; Cardiovascular Diseases; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Norgestrel; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Triglycerides | 1999 |
Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
Topics: Adult; Androgen Antagonists; Area Under Curve; Blood Glucose; Calorimetry; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Fats; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome | 2000 |
Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity.
Topics: Adult; Apolipoproteins B; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Hormonal; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Lipids; Lipoprotein(a); Triglycerides | 2000 |
Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study.
Topics: Adolescent; Adult; Androstenedione; Body Constitution; Body Mass Index; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin | 2002 |
36 other study(ies) available for ethinyl estradiol and Insulin Sensitivity
Article | Year |
---|---|
Insulin resistance and depressed cardiac G6PD activity induced by glucocorticoid exposure during pregnancy are attenuated by maternal estrogen-progestin therapy.
Topics: Animals; Contraceptives, Oral, Combined; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Glucocorticoids; Glucosephosphate Dehydrogenase; Insulin Resistance; Levonorgestrel; Maternal-Fetal Exchange; Myocardium; Pregnancy; Progestins; Rats, Wistar | 2020 |
Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
Topics: Androgen Antagonists; Animals; Apoptosis; Body Weight; Cyproterone Acetate; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Glycolysis; Hypoglycemic Agents; Insulin Resistance; Lactate Dehydrogenase 5; Luteinizing Hormone; Metformin; Ovary; Ovulation; Polycystic Ovary Syndrome; Pyruvate Kinase; Rats; Sirtuin 1; Testosterone | 2020 |
Metformin metabolic and vascular effects in normal weight hyperinsulinemic polycystic ovary syndrome patients treated with contraceptive vaginal ring. A pilot study.
Topics: Adult; Blood Glucose; Brachial Artery; Contraceptive Agents, Hormonal; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Longitudinal Studies; Metformin; Ophthalmic Artery; Pilot Projects; Polycystic Ovary Syndrome; Retrospective Studies; Ultrasonography, Doppler; Vasodilation; Young Adult | 2020 |
Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent.
Topics: Animals; Anti-Inflammatory Agents; Blood Viscosity; Contraceptives, Oral; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Fibrinolytic Agents; Glucocorticoids; Insulin Resistance; Levonorgestrel; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley | 2017 |
Combined oral contraceptive and nitric oxide synthesis inhibition synergistically causes cardiac hypertrophy and exacerbates insulin resistance in female rats.
Topics: Animals; Blood Pressure; C-Reactive Protein; Cardiomegaly; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Insulin Resistance; Levonorgestrel; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plasminogen Activator Inhibitor 1; Rats, Wistar; Uric Acid | 2017 |
Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oestrogen-progestin therapy.
Topics: Administration, Oral; Aldosterone; Animals; Biomarkers; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Glycogen Synthase Kinase 3; Heart; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Levonorgestrel; Myocardium; Nicotine; Nicotinic Agonists; Plasminogen Activator Inhibitor 1; Prediabetic State; Random Allocation; Rats, Wistar | 2018 |
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Topics: Adult; Anti-Obesity Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Young Adult | 2018 |
Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.
Topics: Administration, Oral; Animals; Body Weight; Drug Combinations; Eating; Estradiol; Estrogens; Ethinyl Estradiol; Fasting; Female; Glycogen Synthase Kinase 3; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Levonorgestrel; Mineralocorticoids; Obesity; Rats; Rats, Wistar; Triglycerides | 2018 |
Sodium acetate improves disrupted glucoregulation and hepatic triglyceride content in insulin-resistant female rats: involvement of adenosine deaminase and dipeptidyl peptidase-4 activities.
Topics: Adenosine Deaminase; Animals; Dipeptidyl Peptidase 4; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Insulin Resistance; Levonorgestrel; Liver; Rats, Wistar; Sodium Acetate; Triglycerides; Uric Acid; Xanthine Oxidase | 2019 |
Association between CD16
Topics: Adult; Biomarkers; Case-Control Studies; China; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Insulin Resistance; Metformin; Monocytes; Polycystic Ovary Syndrome; Prospective Studies; Receptors, IgG | 2019 |
Combined oral contraceptive in female mice causes hyperinsulinemia due to β-cell hypersecretion and reduction in insulin clearance.
Topics: Androstenes; Animals; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose; Hyperinsulinism; Insulin; Insulin Resistance; Insulin-Secreting Cells; Mice | 2019 |
Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study.
Topics: Adult; Body Mass Index; Coagulation Protein Disorders; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; India; Inflammation; Insulin; Insulin Resistance; Levonorgestrel; Metformin; Polycystic Ovary Syndrome; Risk Factors; Waist-Hip Ratio; Young Adult | 2019 |
Oral ethinylestradiol-levonorgestrel normalizes fructose-induced hepatic lipid accumulation and glycogen depletion in female rats.
Topics: Administration, Oral; Animals; Antioxidants; Blood Glucose; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Fructose; Glucosephosphate Dehydrogenase; Glycogen; Hyperinsulinism; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Lipid Peroxidation; Liver; Protein Kinases; Rats; Rats, Wistar; Uric Acid | 2019 |
How estrogens prevent from lipid-induced insulin resistance.
Topics: Adipose Tissue; Animals; Diglycerides; Estrogen Replacement Therapy; Estrogens; Ethinyl Estradiol; Female; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Mice; Models, Biological | 2013 |
Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2014 |
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women.
Topics: Adult; Androstenes; Blood Glucose; Cholesterol, HDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Triglycerides | 2014 |
How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
Topics: Adolescent; Adult; Androgen Antagonists; Biomarkers; Blood Platelets; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Leukocyte Count; Mean Platelet Volume; Metformin; Polycystic Ovary Syndrome; Regression Analysis; Treatment Outcome | 2015 |
Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
Topics: Abortion, Spontaneous; Adult; Androgen Antagonists; Blood Glucose; Body Mass Index; Clomiphene; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Live Birth; Luteinizing Hormone; Metformin; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult | 2015 |
Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.
Topics: Adult; Aldosterone; Androstenedione; Androstenes; Blood Pressure; Body Mass Index; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Insulin Resistance; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System; Testosterone; Triglycerides | 2015 |
Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin.
Topics: Adult; Androstenes; Apelin; Blood Glucose; Body Mass Index; Case-Control Studies; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Metformin; Polycystic Ovary Syndrome; Reproductive Control Agents; Young Adult | 2015 |
Homeostasis model assessment-insulin resistance (HOMA-IR), a key role for assessing the ovulation function in polycystic ovary syndrome (PCOS) patients with insulin resistance.
Topics: Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Models, Biological; Ovarian Follicle; Ovary; Ovulation; Polycystic Ovary Syndrome; Sensitivity and Specificity | 2008 |
Oral contraception enhances growth hormone responsiveness to hyper- and hypoglycaemia.
Topics: Adult; Analysis of Variance; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Human Growth Hormone; Humans; Hyperglycemia; Hypoglycemia; Insulin Resistance; Prospective Studies | 2012 |
Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome.
Topics: Adiposity; Adolescent; Adult; Androgen Antagonists; Body Fat Distribution; Carotid Intima-Media Thickness; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metabolic Syndrome; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2012 |
Severe hyperandrogenemia and insulin resistance in a 12-year-old girl.
Topics: Child; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Testosterone | 2012 |
Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency.
Topics: 46, XX Disorders of Sex Development; Adolescent; Adrenal Hyperplasia, Congenital; Aromatase; Bone Density; Child Development; Child, Preschool; DNA Mutational Analysis; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Fludrocortisone; Growth Disorders; Gynecomastia; Humans; Hydrocortisone; Infertility, Male; Insulin Resistance; Male; Metabolism, Inborn Errors; Mutation, Missense; Pedigree; Sexual Maturation | 2012 |
Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Apolipoproteins A; Apolipoproteins B; Blood Glucose; Body Composition; Body Constitution; Body Mass Index; Body Weight; C-Peptide; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Insulin; Insulin Resistance; Leptin; Lipoprotein(a); Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 2003 |
Retinol binding protein 4, low birth weight-related insulin resistance and hormonal contraception.
Topics: Adult; Age of Onset; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Insulin Resistance; Logistic Models; Prospective Studies; Retinol-Binding Proteins, Plasma; Sex Hormone-Binding Globulin; Triglycerides | 2007 |
Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS).
Topics: Adult; Androgens; Arginine; Body Mass Index; Case-Control Studies; Contraceptives, Oral; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadotropins; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Time Factors | 2008 |
The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism.
Topics: Acne Vulgaris; Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Fasting; Female; Glucose Tolerance Test; Hirsutism; Humans; Insulin; Insulin Resistance; Tolbutamide | 1984 |
Induction of insulin resistance by androgens and estrogens.
Topics: Adolescent; Adult; Blood Glucose; Carrier Proteins; Cyproterone Acetate; Ethinyl Estradiol; Female; Glucose Clamp Technique; Humans; Hydrocortisone; Insulin; Insulin Resistance; Male; Sex Hormone-Binding Globulin; Testosterone | 1994 |
Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy.
Topics: Acanthosis Nigricans; Adolescent; Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Insulin Resistance; Remission Induction; Spironolactone; Syndrome | 1997 |
Effects of LY117018 and the estrogen analogue, 17alpha-ethinylestradiol, on vascular reactivity, platelet aggregation, and lipid metabolism in the insulin-resistant JCR:LA-cp male rat: role of nitric oxide.
Topics: Animals; Aorta; Blood Pressure; Body Weight; Cholesterol Esters; Eating; Enzyme Inhibitors; Estradiol Congeners; Estrogen Antagonists; Ethinyl Estradiol; Insulin Resistance; Lipid Metabolism; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Aggregation; Pyrrolidines; Rats; Thiophenes; Triglycerides; Vasoconstriction | 2001 |
Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
Topics: Acanthosis Nigricans; Adolescent; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Diabetes Mellitus; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Hypertension; Insulin Resistance; Progesterone Congeners; Syndrome | 1997 |
Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Levonorgestrel; Norgestrel; Pregnancy; Pregnancy in Diabetics | 1987 |
Prolonged suppression of hirsutism with combination therapy in an adolescent with insulin resistance and acanthosis nigricans.
Topics: Acanthosis Nigricans; Adolescent; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin Resistance; Norethindrone; Spironolactone; Syndrome | 1987 |
Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
Topics: Administration, Oral; Adolescent; Adult; Arginine; Blood Glucose; Contraceptives, Oral, Combined; Drug Combinations; Female; Glucagon; Glucose Tolerance Test; Humans; Infusions, Parenteral; Insulin; Insulin Resistance; Mestranol; Norethindrone | 1983 |